Smart Assays
Rehovot, Israel· Est.
GLP‑certified CRO delivering high‑quality immunology and cell biology services for early‑stage biotech development.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
GLP‑certified CRO delivering high‑quality immunology and cell biology services for early‑stage biotech development.
ImmunologyCell BiologyOncology
Technology Platform
A service platform integrating GLP‑compliant high‑throughput immunology, cell biology, and histopathology assays using MSD multiplex, flow cytometry, single‑cell proteomics, and advanced analytical instrumentation.
Opportunities
Increasing demand for specialized immunology and cell‑biology CRO services, especially for biologics, cell therapies, and RNA‑based modalities, offers growth through service expansion and geographic outreach.
Risk Factors
Intense competition from larger global CROs, pricing pressure, and reliance on the biotech funding environment could constrain growth.
Competitive Landscape
Competes with major CROs such as Charles River, Eurofins, and WuXi AppTec; differentiates through deep scientific expertise, rapid turnaround, and a collaborative partnership model.